Enora Clero

Enora Clero

Auto-generated profile, based on publicly available information

Enora Clero

Health and Environmental Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
CMClaire Marant Micallef
Claire Marant Micallef
KSKevin David Shield
Kevin David Shield
JVJérôme Vignat
Jérôme Vignat
IBIsabelle BALDI
Isabelle BALDI
BCBarbara Charbotel
Barbara Charbotel
ISIsabelle Soerjomataram
Isabelle Soerjomataram

8 May 2018 in Radiation and Environmental Biophysics
Verified
Journal Article
Closed access
PDF file
RARoula Ajrouche
Roula Ajrouche
CRCandice Roudier
Candice Roudier
ECEnora Cléro
Enora Cléro
GIGéraldine Ielsch
Géraldine Ielsch
DGDidier Gay
Didier Gay
DLDominique Laurier
Dominique Laurier

1 March 2015 in BMC Genomic Data
Verified
Journal Article
Open access
PDF file
CPCelia M Pereda
Celia M Pereda
FLFabienne Lesueur
Fabienne Lesueur
MPMaroulio Pertesi
Maroulio Pertesi
NRNivonirina Robinot
Nivonirina Robinot
JLJuan J Lence-Anta
Juan J Lence-Anta
FVFlorent De Vathaire
Florent De Vathaire
The incidence of differentiated thyroid carcinoma (DTC) in Cuba is low and the contribution of host genetic factors to DTC in this population has not been investigated so far. Our goal was to assess the role of known risk polymorphisms in DTC cases living in Havana. We genotyped five polymorphisms located at the DTC susceptibility loci on chromosome 14q13.3 near NK2 homeobox 1 (NKX2-1), on chromosome 9q22.33 near Forkhead factor E1 (FOXE1) and within the DNA repair gene Ataxia-Telangiectasia Mutated (ATM) in 203 cases and 212 age- and sex- matched controls. Potential interactions between these polymorphisms and other DTC risk factors such as body surface area, body mass index, size, ethnicity, and, for women, the parity were also examined. Significant association with DTC risk was found for rs944289 near NKX2-1 (OR per A allele = 1.6, 95% CI: 1.2–2.1), and three polymorphisms near or within FOXE1, namely rs965513 (OR per A allele = 1.7, 95% CI: 1.2–2.3), rs1867277 in the promoter region of the gene (OR per A allele = 1.5, 95% CI: 1.1–1.9) and the poly-alanine tract expansion polymorphism rs71369530 (OR per Long Allele = 1.8, 95% CI: 1.3–2.5), only the 2 latter remaining significant when correcting for multiple tests. Overall, no association between DTC and the coding SNP D1853N (rs1801516) in ATM (OR per A Allele = 1.1, 95% CI: 0.7–1.7) was seen. Nevertheless women who had 2 or more pregnancies had a 3.5-fold increase in risk of DTC if they carried the A allele (OR 3.5, 95% CI: 3.2–9.8) as compared to 0.8 (OR 0.8, 95% CI: 0.4–1.6) in those who had fewer than 2. We confirmed in the Cuban population the role of the loci previously associated with DTC susceptibility in European and Japanese populations through genome-wide association studies. Our results on ATM and the number of pregnancies raise interesting questions on the mechanisms by which oestrogens, or other hormones, alter the DNA damage response and DNA repair through the regulation of key effector proteins such as ATM. Due to the small size of our study and to multiple tests, all these results warrant further investigation.

1 January 2021 in Environment International
Verified
Journal Article
Open access
ECEnora Cléro
Enora Cléro
EOEvgenia Ostroumova
Evgenia Ostroumova
CDClaire Demoury
Claire Demoury
BGBernd Grosche
Bernd Grosche
AKAusrele Kesminiene
Ausrele Kesminiene
ECElisabeth Cardis
Elisabeth Cardis
Exposure of the thyroid gland to ionizing radiation at a young age is the main recognized risk factor for differentiated thyroid cancer. After the Chernobyl and Fukushima nuclear accidents, thyroid cancer screening was implemented mainly for children, leading to case over-diagnosis as seen in South Korea after the implementation of opportunistic screening (where subjects are recruited at healthcare sites). The aim of cancer screening is to reduce morbidity and mortality, but screening can also cause negative effects on health (with unnecessary treatment if over-diagnosis) and on quality of life. This paper from the SHAMISEN special issue (Nuclear Emergency Situations - Improvement of Medical And Health Surveillance) presents the principles of cancer screening, the lessons learned from thyroid cancer screening, as well as the knowledge on thyroid cancer incidence after exposure to iodine-131. The SHAMISEN Consortium recommends to envisage systematic health screening after a nuclear accident, only when appropriately justified, i.e. ensuring that screening will do more good than harm. Based on the experience of the Fukushima screening, the consortium does not recommend mass or population-based thyroid cancer screening, as the negative psychological and physical effects are likely to outweigh any possible benefit in affected populations; thyroid health monitoring should however be made available to persons who request it (regardless of whether they are at increased risk or not), accompanied with appropriate information and support.

25 September 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
AHAfi Mawulawoe Sylvie Henyoh
Afi Mawulawoe Sylvie Henyoh
OLOlivier Laurent
Olivier Laurent
CMCorinne Mandin
Corinne Mandin
ECEnora Clero
Enora Clero
Context and objective: To date, lung cancer is the only well-established health effect associated with radon exposure in humans. To summarize available evidence on other potential health effects of radon exposure, we performed a comprehensive qualitative and quantitative synthesis of the available literature on radon exposure and health effects other than lung cancer, in both occupational and general populations.Method: Eligible studies published from January 1990 to March 2023, in English and French languages, were identified in PubMed, ScienceDirect, Scopus, ScieLo and HAL. In the meta-analysis, we estimated average weighted standardized incidence ratios (metaSIR), standardized mortality ratios (metaSMR), and risk ratio (metaRR) per 100 unit (Bq/m3 or Working level Month) increase in radon exposure concentration by combining estimates from the eligible studies using the random-effect inverse variance method. DerSimonian & Laird estimator was used to estimate the between-study variance. For each health outcome, analyses were performed separately for mine workers, children, and adults in the general population.Results: A total of 129 studies were included in the systematic review and 40 distinct studies in the meta-analysis. For most of these health outcomes, the results of the meta-analyses showed no statistically significant association, and heterogeneity was only present among occupational studies, especially between those included in the metaSIR or metaSMR analyses. However, the estimated exposure-risk associations were positive and close to the statistical significance threshold for: lymphohematological cancer incidence in children (metaRR = 1.01; 95%CI: 1.00–1.03; p = 0.08); malignant melanoma mortality among adults in the general population (metaRR = 1.10; 95%CI: 0.99–1.21; p = 0.07); liver cancer mortality among mine workers (metaRR = 1.04; 95%CI: 1.00–1.10; p = 0.06); intestine and rectal cancer mortality combined among mine workers (metaRR = 1.02; 95%CI: 1.00–1.04; p = 0.06).Conclusion: Although none of the exposure-risk associations estimated in the meta-analyses reached statistical significance, the hypothesis that radon may have other health effects apart from lung cancer could not be ruled-out and call for additional research. Larger and well-designed studies are needed to further investigate this question.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023474542, ID: CRD42023474542.

29 April 2022 in Journal of Radiological Protection
Verified
Journal Article
Closed access
NBNobuhiko Ban
Nobuhiko Ban
ECEnora Cléro
Enora Cléro
LVLudovic Vaillant
Ludovic Vaillant
WZWei Zhang
Wei Zhang
Nobuyuki HamadaNobuyuki Hamada
Nobuyuki Hamada
DLDominique Laurier
Dominique Laurier
Radiation detriment is a concept to quantify the burden of stochastic effects from exposure of the human population to low-dose and/or low-dose-rate ionising radiation. As part of a thorough review of the system of radiological protection, the International Commission on Radiological Protection (ICRP) has compiled a report on radiation detriment calculation methodology as Publication 152. It provides a historical review of the detriment calculation with details of the procedure used in ICRP Publication 103. A selected sensitivity analysis was conducted to identify the parameters and calculation conditions that can be major sources of variation and uncertainty. It has demonstrated that sex, age at exposure, dose and dose-rate effectiveness factor, dose assumption in the lifetime risk calculation, and lethality fraction have a substantial impact on the calculated values of radiation detriment. Discussions are also made on the issues to be addressed and possible ways for improvement toward the revision of general recommendations. These include update of the reference population data and cancer severity parameters, revision of cancer risk models, and better handling of the variation with sex and age. Finally, emphasis is placed on transparency and traceability of the calculation, along with the need to improve the way of expressing and communicating the detriment.